EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Characterization of SHARPIN knockout Syrian hamsters developed using CRISPR /Cas9 system

Jinxin Miao iD, Tianfeng Lan, Haoran Guo, Jianyao Wang, Guangtao Zhang, Zheng Wang, Panpan Yang, Haoze Li, Chunyang Zhang, Yaohe Wang, Xiu-Min Li, Mingsan Miao

Animal Models and Experimental Medicine · 2023-10 · 6 (5) · 489-498

DOI: 10.1002/ame2.12265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 12.09.2022. Verfasst von Jinxin Miao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China. Hauptthemen laut MEDLINE: NF-kappa B, CRISPR-Cas Systems. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation, Henan Postdoctoral Science Foundation, Natural Science Foundation of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

SHARPIN (SHANK‐associated RH domain interactor) is a component of the linear ubiquitination complex that regulates the NF‐κB signaling pathway. To better understand the function of SHARPIN, we sought to establish a novel genetically engineered Syrian hamster with SHARPIN disruption using the CRISPR/Cas9 system.

Methods

A single‐guide ribonucleic acid targeting exon 1 of SHARPIN gene was designed and constructed. The zygotes generated by cytoplasmic injection of the Cas9/gRNA ribonucleoprotein were transferred into pseudopregnant hamsters. Neonatal mutants were identified by genotyping. SHARPIN protein expression was detected using Western blotting assay. Splenic, mesenteric lymph nodes (MLNs), and thymic weights were measured, and organ coefficients were calculated. Histopathological examination of the spleen, liver, lung, small intestine, and esophagus was performed independently by a pathologist. The expression of lymphocytic markers and cytokines was evaluated using reverse transcriptase‐quantitative polymerase chain reaction.

Results

All the offspring harbored germline‐transmitted SHARPIN mutations. Compared with wild‐type hamsters, SHARPIN protein was undetectable in SHARPIN −/− hamsters. Spleen enlargement and splenic coefficient elevation were spotted in SHARPIN −/− hamsters, with the descent of MLNs and thymuses. Further, eosinophil infiltration and structural alteration in spleens, livers, lungs, small intestines, and esophagi were obvious after the deletion of SHARPIN. Notably, the expression of CD94 and CD22 was downregulated in the spleens of knockout (KO) animals. Nonetheless, the expression of CCR3, CCL11, Il4 , and Il13 was upregulated in the esophagi. The expression of NF‐κB and phosphorylation of NF‐κB and IκB protein significantly diminished in SHARPIN −/− animals.

Conclusions

A novel SHARPIN KO hamster was successfully established using the CRISPR/Cas9 system. Abnormal development of secondary lymphoid organs and eosinophil infiltration in multiple organs reveal its potential in delineating SHARPIN function and chronic inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BCRISPR-Cas SystemsAnimalsCricetinaeMesocricetusAnimals, Genetically ModifiedNerve Tissue Proteins

Stichwörter der Autor:innen

CRISPR/Cas9Sharpineosinophil infiltrationgolden hamstersecondary lymphoid organs

Substanzen

NF-kappa BsharpinNerve Tissue Proteins

Autor:innen und Institutionen

  • Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China.
  • Sino-British Research Center for Molecular Oncology, National Center for the International Research in Cell and Gene Therapy, School of Basic Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan…
  • Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
  • Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Department of General Thoracic Surgery, Hami Central Hospital, Hami, Xinjiang, People's Republic of China.
  • Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.

ORCID-Profile: Jinxin Miao

Förderung

  • China Postdoctoral Science Foundation
  • Henan Postdoctoral Science Foundation
  • Natural Science Foundation of Henan Province

Zitieren

APA

Miao, J., Lan, T., Guo, H., Wang, J., Zhang, G., Wang, Z., Yang, P., Li, H., Zhang, C., Wang, Y., Li, X. M., & Miao, M. (2023). Characterization of SHARPIN knockout Syrian hamsters developed using CRISPR /Cas9 system. Animal Models and Experimental Medicine, 6(5), 489-498. https://doi.org/10.1002/ame2.12265

Vancouver

Miao J, Lan T, Guo H, Wang J, Zhang G, Wang Z, et al. Characterization of SHARPIN knockout Syrian hamsters developed using CRISPR /Cas9 system. Animal Models and Experimental Medicine. 2023;6(5):489-498. doi:10.1002/ame2.12265

BibTeX
@article{Miao2023,
  author = {Miao, Jinxin and Lan, Tianfeng and Guo, Haoran and Wang, Jianyao and Zhang, Guangtao and Wang, Zheng and Yang, Panpan and Li, Haoze and Zhang, Chunyang and Wang, Yaohe and Li, Xiu-Min and Miao, Mingsan},
  title = {Characterization of SHARPIN knockout Syrian hamsters developed using CRISPR /Cas9 system},
  journal = {Animal Models and Experimental Medicine},
  year = {2023},
  volume = {6},
  number = {5},
  pages = {489--498},
  doi = {10.1002/ame2.12265}
}
Kostenlos starten →